Target (CBDY) Receivables (2016 - 2026)
Target (CBDY) reported Receivables of $458352.0 for Q1 2026, down 29.38% year-over-year from $649042.0 in Q1 2025, and up 2.7% quarter-over-quarter from $446283.0 in Q4 2025.
Target (CBDY) Receivables (2016 - 2026) Analysis & Trends
Target (CBDY) has 10 years of Receivables data on file, last reported at $458352.0 in Q1 2026.
- Receivables for Q1 2026 came in at $458352.0, down 29.38% year-over-year; the trailing twelve-month figure through Mar 2026 was $458352.0 (down 29.38% YoY), and the FY2025 annual result was $446283.0, up 319.34% from the prior year.
- Receivables rose to $458352.0 in Q1 2026 per CBDY's latest filing, from $446283.0 in the prior quarter.
- Over five years, Receivables peaked at $1.0 million in Q4 2023 and troughed at $5716.0 in Q3 2022.
- A 5-year average of $241934.3 and a median of $106426.0 in 2024 frame the typical range for Receivables.
- The sharpest annual moves came in 2023 and 2024: Receivables jumped 17900.67% in 2023, then tumbled 89.72% in 2024.
- A 5-year view of Receivables shows it stood at $5751.5 in 2022, then jumped by 17900.67% to $1.0 million in 2023, then plunged by 89.72% to $106426.0 in 2024, then soared by 319.34% to $446283.0 in 2025, then climbed by 2.7% to $458352.0 in 2026.
- Business Quant data shows CBDY's Receivables at $458352.0 in Q1 2026, $446283.0 in Q4 2025, and $316133.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 3.39 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 1.51 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 312.00 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 31.29 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 768.10 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 1.15 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 407.63 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 149.62 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 355.67 Mn |
| 10 | Target | - | - | 191,787.00 | 458,352.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 458,352.00 |
| Dec 31, 2025 | 446,283.00 |
| Sep 30, 2025 | 316,133.00 |
| Jun 30, 2025 | 315,559.00 |
| Mar 31, 2025 | 649,042.00 |
| Dec 31, 2024 | 106,426.00 |
| Sep 30, 2024 | 49,933.00 |
| Jun 30, 2024 | 476,419.00 |
| Mar 31, 2024 | 92,389.00 |
| Dec 31, 2023 | 1.04 Mn |
| Sep 30, 2023 | 131,942.00 |
| Jun 30, 2023 | 5,845.00 |
| Mar 31, 2023 | 5,763.00 |
| Dec 31, 2022 | 5,751.51 |
| Sep 30, 2022 | 5,716.00 |
| Jun 30, 2022 | 5,948.00 |
| Mar 31, 2022 | 6,070.00 |
| Dec 31, 2021 | 6,034.68 |
| Sep 30, 2021 | 5,993.00 |
| Jun 30, 2021 | 6,102.00 |